* Viveve Medical Inc VIVE.OQ reported a quarterly adjusted
loss
of 67 cents per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 67
cents per share.
* Revenue rose 13.2% to $1.64 million from a year ago;
analysts
expected $1.74 million.
* Viveve Medical Inc's reported EPS for the quarter was a
loss
of 67 cents.
* The mean earnings estimate of analysts had fallen by
about 20.5%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Viveve Medical Inc shares had fallen by 29.2% this
quarter and
lost 34.2% so far this year.
* The company reported a quarterly loss of $7.15 million.
* Wall Street's median 12-month price target for Viveve
Medical
Inc is $6.88
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated May 12 at 09:00 p.m. All
figures in US dollars unless otherwise stated